Career Development Program in Substance Use and Addiction Medicine
药物滥用和成瘾医学职业发展计划
基本信息
- 批准号:10675872
- 负责人:
- 金额:$ 53.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:Applications GrantsClinicalClinical ResearchCollaborationsDedicationsDrug AddictionDrug abuseEnsureEnvironmentFosteringGeneral HospitalsGoalsGovernmentGroup MeetingsHospitalsIndividualIndustryInstitutionJointsLaboratory ResearchLeadershipMassachusettsMedicalMedicineMentored Clinical Scientist Development Award (K08)Mentored Clinical Scientist Development ProgramMentorsMentorshipNational Institute of Drug AbusePaperPostdoctoral FellowProductivityProgram DevelopmentPsychiatryPublic HealthRecording of previous eventsResearchResearch PersonnelResourcesRoleScientistSubstance AddictionTalentsTrainingTraining ProgramsVisionWorkWritingaddictioncareercareer developmentcatalystdesignexperienceimprovedinterestmedical schoolsmembermultidisciplinarynext generationpatient orientedprofessorprogramsrecruitresearch and developmentresponsible research conductrole modelskillssubstance usetraining opportunity
项目摘要
Project Summary
Training the next generation of clinician-investigators to conduct transformational, independent, patient-
oriented addiction research that will improve the lives of those with addictive disorders is of the highest public
health importance and is the primary goal of this MGH K12 Mentored Clinical Scientist Development Award in
Drug Abuse and Addiction renewal application. This renewal will support and strengthen a multidisciplinary 2-3
year program of intensive training, mentored research, and dedicated career development mentorship for
diverse, talented, post-doctoral clinician-scientists committed to independent research careers in patient-
oriented addiction research provided in the rich training environment of addiction research laboratories based
at the Massachusetts General Hospital (MGH), with advanced didactic training opportunities at MGH, McLean
Hospital, and Harvard Medical School (HMS). These resources will continue to be individually tailored to each
scholar’s interests in order to provide the focused, concentrated training and mentorship experience to
optimally advance each Scholar’s productive, independent, impactful addiction-focused work, preparing them
for leadership roles in clinical and academic medicine, government and industry. Career development support
in the renewal will be bolstered by collaboration with a new national consortium of NIDA K12 scholars and
mentors. Eden Evins, MD, MPH, and Nancy Rigotti, MD, will partner again as joint-PIs to lead the career
development program renewal, supervising scholars’ research and career development, academic productivity,
and progress to independence in patient-oriented addiction research. They are committed to attracting a
diverse group of superb clinically-trained scholars, guided by an expanded Executive Committee and a 3-
member Advisory Board of experienced leaders of successful postgraduate medical training programs to
identify, recruit, retain and foster the career development of underrepresented in medicine (UiM) Scholar
candidates. The mPIs are HMS Professors in the Departments of Psychiatry (Dr. Evins) and Medicine (Dr.
Rigotti). They and their departments have a long history of productive collaboration and a shared vision for
expanding a diverse, independent clinical addiction research workforce. The program has strong institutional
support from MGH leadership. Dr. Evins’ and Rigotti’s co-leadership ensures that K12 scholars have access to
a multi-departmental program of multi-disciplinary training. The mentoring plan includes training scholars to 1)
acquire the research skills needed to design and implement clinical studies in addiction medicine; 2) prepare
scientific papers and presentations; 3) write successful grant applications; 4) conduct research responsibly,
and 5) launch independent careers in patient-oriented addiction research. They will accomplish this with
tailored course work, individual and group meetings, collaborative mentoring, and role modeling integrated with
the rich mentoring resources available through the MGH Division of Clinical Research and the Harvard
Catalyst (CTSC) Program.
项目概要
培训下一代临床医生-研究者进行变革性的、独立的、患者-
旨在改善成瘾性疾病患者生活的成瘾研究是最受公众关注的
健康重要性,是 MGH K12 指导临床科学家发展奖的主要目标
药物滥用和成瘾续签申请 本次续签将支持和加强多学科 2-3。
年强化培训、指导研究和专门职业发展指导计划
多元化、才华横溢的博士后临床医生科学家致力于患者的独立研究事业
以成瘾研究实验室为基础的丰富的培训环境提供定向成瘾研究
在马萨诸塞州总医院 (MGH) 获得高级教学培训机会
医院和哈佛医学院 (HMS) 将继续针对每个机构量身定制这些资源。
学者的兴趣,以便提供有针对性的、集中的培训和指导经验
最佳地推进每位学者富有成效的、独立的、有影响力的以成瘾为中心的工作,为他们做好准备
在临床和学术医学、政府和行业中发挥领导作用。
与 NIDA K12 学者组成的新国家联盟的合作将推动更新的进程
Eden Evins(医学博士、公共卫生硕士)和 Nancy Rigotti(医学博士)将再次作为联合 PI 合作,领导其职业生涯。
发展计划更新,监督学者的研究和职业发展,学术生产力,
他们致力于吸引以患者为导向的成瘾研究的独立性。
一个由受过临床训练的优秀学者组成的多元化群体,由扩大的执行委员会和 3-
由成功的研究生医学培训项目的经验丰富的领导者组成的咨询委员会成员
识别、招募、保留和促进医学领域代表性不足的学者 (UiM) 学者的职业发展
mPI 是 HMS 精神病学系(埃文斯博士)和医学系(埃文斯博士)的教授。
他们和他们的部门有着悠久的富有成效的合作历史和共同的愿景。
该计划拥有强大的机构,扩大了多元化、独立的临床成瘾研究队伍。
Evins 博士和 Rigotti 的共同领导的支持确保 K12 学者能够获得
多部门多学科培训计划包括培训学者:1)
获得设计和实施成瘾医学临床研究所需的研究技能;2) 准备;
科学论文和演示文稿;3)撰写成功的资助申请;4)负责任地进行研究;
5)在以患者为导向的成瘾研究中开展独立的职业他们将通过以下方式实现这一目标。
量身定制的课程作业、个人和小组会议、协作指导以及与
MGH 临床研究部和哈佛大学提供丰富的指导资源
催化剂 (CTSC) 计划。
项目成果
期刊论文数量(47)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unexpected term NICU admissions: a marker of obstetrical care quality?
- DOI:10.1016/j.ajog.2019.02.001
- 发表时间:2019-04
- 期刊:
- 影响因子:9.8
- 作者:Clapp MA;James KE;Bates SV;Kaimal AJ
- 通讯作者:Kaimal AJ
National Trends in Suicide Thoughts and Behavior among US Adults with Opioid Use Disorder from 2015 to 2020.
- DOI:10.1080/10826084.2022.2046102
- 发表时间:2022
- 期刊:
- 影响因子:2
- 作者:Streck, Joanna M.;Parker, Maria A.;Bearnot, Benjamin;Kalagher, Kelly;Sigmon, Stacey C.;Goodwin, Renee D.;Weinberger, Andrea H.
- 通讯作者:Weinberger, Andrea H.
Moderators of a resiliency group intervention for frontline clinicians during the COVID-19 pandemic.
- DOI:10.1016/j.jad.2021.06.036
- 发表时间:2021-10-01
- 期刊:
- 影响因子:6.6
- 作者:Sylvia LG;George N;Rabideau DJ;Streck JM;Albury E;Hall DL;Luberto CM;Mizrach HR;Perez GK;Crute S;Mehta DH;Convery MS;Looby SE;Fricchione G;Fava M;Wilhelm S;Park ER
- 通讯作者:Park ER
Observation of racial differences in the use of physical restraint: Response to Taylor et al. commentary "Premature conclusions".
观察身体束缚使用中的种族差异:对泰勒等人的回应
- DOI:10.1111/acem.14150
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Macias-Konstantopoulos,Wendy;Schnitzer,Kristina;Merideth,Flannery;Hayden,Douglas;Shtasel,Derri;Bird,Suzanne
- 通讯作者:Bird,Suzanne
Intersectionality of serious psychological distress, cigarette smoking, and substance use disorders in the United States: 2008-2018.
- DOI:10.1016/j.drugalcdep.2021.109095
- 发表时间:2021-11-01
- 期刊:
- 影响因子:4.2
- 作者:Parker MA;Cordoba-Grueso WS;Streck JM;Goodwin RD;Weinberger AH
- 通讯作者:Weinberger AH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A EDEN EVINS其他文献
A EDEN EVINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A EDEN EVINS', 18)}}的其他基金
Research Supplement to Promote Diversity in Health-Related Research: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
促进健康相关研究多样性的研究补充:伐尼克兰对青少年非吸烟者戒烟尼古丁的随机对照试验
- 批准号:
10878366 - 财政年份:2021
- 资助金额:
$ 53.35万 - 项目类别:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
慢性非癌性疼痛患者的医用大麻、疼痛和阿片类药物的使用
- 批准号:
10641911 - 财政年份:2021
- 资助金额:
$ 53.35万 - 项目类别:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
慢性非癌性疼痛患者的医用大麻、疼痛和阿片类药物的使用
- 批准号:
10211907 - 财政年份:2021
- 资助金额:
$ 53.35万 - 项目类别:
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
伐尼克兰用于青少年非吸烟者戒烟尼古丁的随机对照试验
- 批准号:
10689064 - 财政年份:2021
- 资助金额:
$ 53.35万 - 项目类别:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
慢性非癌性疼痛患者的医用大麻、疼痛和阿片类药物的使用
- 批准号:
10491683 - 财政年份:2021
- 资助金额:
$ 53.35万 - 项目类别:
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
伐尼克兰用于青少年非吸烟者戒烟尼古丁的随机对照试验
- 批准号:
10298337 - 财政年份:2021
- 资助金额:
$ 53.35万 - 项目类别:
Administrative Supplement: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
行政补充:伐尼克兰用于青少年非吸烟者戒烟尼古丁的随机对照试验
- 批准号:
10878378 - 财政年份:2021
- 资助金额:
$ 53.35万 - 项目类别:
Advancing a novel portable detection method for cannabis intoxication
推进一种新型便携式大麻中毒检测方法
- 批准号:
10145857 - 财政年份:2017
- 资助金额:
$ 53.35万 - 项目类别:
Career Development Program in Substance Use and Addiction Medicine
药物滥用和成瘾医学职业发展计划
- 批准号:
10215450 - 财政年份:2017
- 资助金额:
$ 53.35万 - 项目类别:
Advancing a novel portable detection method for cannabis intoxication
推进一种新型便携式大麻中毒检测方法
- 批准号:
9751264 - 财政年份:2017
- 资助金额:
$ 53.35万 - 项目类别:
相似国自然基金
周边与中央视觉拥挤效应的心理物理学与脑机制研究及临床应用
- 批准号:32371097
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
- 批准号:82302605
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MicroRNA-23a/HMGN2通过染色质重塑调控中性粒细胞抗细菌免疫的作用机制及其临床检测价值研究
- 批准号:82302630
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DDX3Y调控Wnt/β-catenin信号通路在肿瘤免疫治疗疗效中的机制和临床价值研究
- 批准号:82372331
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于先进深度学习模型的面向临床多模态乳腺癌诊断方法研究
- 批准号:62371312
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 53.35万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 53.35万 - 项目类别:
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose
经皮膈神经刺激治疗阿片类药物过量
- 批准号:
10681111 - 财政年份:2023
- 资助金额:
$ 53.35万 - 项目类别:
Patient oriented research and mentoring program in dermatologic diseases
以患者为中心的皮肤病研究和指导计划
- 批准号:
10685455 - 财政年份:2023
- 资助金额:
$ 53.35万 - 项目类别:
Society of Ears, Nose, and Throat Advances in Children (SENTAC)
儿童耳鼻喉协会 (SENTAC)
- 批准号:
10683579 - 财政年份:2023
- 资助金额:
$ 53.35万 - 项目类别: